Stay updated on IMGN632 in AML: Clinical Trial
Sign up to get notified when there's something new on the IMGN632 in AML: Clinical Trial page.

Latest updates to the IMGN632 in AML: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date of December 17, 2024. Additionally, a new date of February 24, 2025, has been added.SummaryDifference6%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check43 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check58 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check65 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check87 days agoChange DetectedAbbVie has been added with a date of 2024-12-17, while ImmunoGen, Inc. has been removed effective 2024-04-18.SummaryDifference2%
Stay in the know with updates to IMGN632 in AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMGN632 in AML: Clinical Trial page.